Advertise on podcast: Inside Scope

Welcome to our two-episode series: MD3D: Metabolic dysfunction-associated steatohepatitis — The Role of Primary Care providers in the Growing Epidemic. These episodes have been developed in partnership between American Gastroenterological Association (AGA) and Projects In Knowledge (PIK) Powered By Kaplan and are featured on both AGA’s Inside Scope podcast as well as PIK’s Morning Commute podcast. In episode one, “Recognizing a ‘Silent’ Disease,” Drs. Arun Sanyal and Mary Rinella will discuss MASH and the role that primary care physicians can play in its early detection and treatment. What are the challenges in diagnosing this often-silent disease? What do clinicians need to know to ensure that MASH doesn't fall off their radar? Listen as experts discuss challenges in MASLD/MASH diagnosis, including risk stratification of patients, and implications for diagnostic delays. Additionally, they’ll share strategies for incorporating noninvasive methods such as the FIB-4 score, NFS, APRI, and secondary assessments. Finally, the experts will emphasize the vital role PCPs play in MASH detection and management. This program is supported by an educational grant from Novo Nordisk. Information about the faculty and disclosures can be found by visiting: https://suitehome.atpointofcare.com/library/2711.01/page/0?subdomain=mash. You can also use this link to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

Welcome to our two-episode series: MD3D: Metabolic dysfunction-associated steatohepatitis — The Role of Primary Care providers in the Growing Epidemic. These episodes have been developed in partnership between American Gastroenterological Association (AGA) and Projects In Knowledge (PIK) Powered By Kaplan and are featured on both AGA’s Inside Scope podcast as well as PIK’s Morning Commute podcast. In episode two, “MASH: How to Treat and When to Refer,” Drs. Arun Sanyal and Mary Rinella take a look at the role that primary care physicians can play in the treatment of MASH, how can they treat and monitor these patients, and most importantly, when should a specialist be called in. Our experts will review current treatment guidelines and care pathways for MASH. They’ll discuss the role of PCPs in the multidisciplinary management of patients with MASH, including the referral of high-risk patients to specialists. Finally, they’ll share the management of underlying metabolic conditions, such as T2DM and obesity, in patients with MASH who are at low risk of fibrosis. This program is supported by an educational grant from Novo Nordisk. Information about the faculty and disclosures can be found by visiting : https://suitehome.atpointofcare.com/library/2711.02/page/0?subdomain=mash. You can also use this link to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

Welcome to episode one of our six-part series AGA Expert Exchange: Nutrition in IBD. Our hosts Dr. Eric Vasiliauskas and Kelly Issokson, RD, LDN, are joined by guest Dr. Dale Lee to discuss the role of diet as a therapeutic approach for managing inflammatory bowel disease (IBD). The discussion will cover the distinction between symptoms and disease control, the use of enteral nutrition therapies, and the benefits of whole food-based diets. We will explore how exclusive enteral nutrition can be used to treat conditions like Crohn's disease and the importance of a close partnership with a dietitian. Our experts will also address the challenges and opportunities of using dietary therapy for IBD, including differences in nutritional therapy for adult versus pediatric patients and the future landscape of nutrition and IBD management. To view additional resources on nutrition in IBD and claim CME, please visit AGA University at agau.gastro.org This independent educational program was supported by an independent medical education grant from Pfizer

Welcome to episode two of our six-part series AGA Expert Exchange: Nutrition in IBD. Our hosts Dr. Eric Vasiliauskas and Kelly Issokson, RD, LDN, are joined by Rotem Sigall Boneh, RD, to explore the essential aspects of integrating nutritional expertise into inflammatory bowel disease (IBD) management. This episode will cover how to effectively collaborate with a GI dietitian, emphasizing strategies for personalizing dietary interventions to ensure the right diet is matched to the right patient at the right time. Additionally, the group discusses the practicalities of referring patients to a dietitian and clarifies the differences between a nutritionist and a registered dietitian, helping health care providers make informed decisions about patient care. To view additional resources on nutrition in IBD and claim CME, please visit AGA University at agau.gastro.org This independent educational program was supported by an independent medical education grant from Pfizer

Welcome to episode three of our six-part series AGA Expert Exchange: Nutrition in IBD. Our hosts Dr. Eric Vasiliauskas and Kelly Issokson, RD, LDN, are joined by Victoria Christianson, RD, to explore the critical topic of malnutrition in inflammatory bowel disease (IBD). The discussion will begin with practical approaches to screening and assessment, highlighting key red flags that clinicians should recognize in both outpatient and inpatient settings. The conversation will then delve into the dual challenges of sarcopenia and obesity, examining how variations in fat mass can influence the clinical course of IBD and impact patient outcomes. Listeners will gain insights into the nuances of managing nutrition for ambulatory versus hospitalized patients, including considerations for those with NPO status. The episode will provide actionable strategies for identifying at-risk patients, tailoring interventions, and collaborating with multidisciplinary teams to optimize nutritional care across the continuum of IBD management. To view additional resources on nutrition in IBD and claim CME, please visit AGA University at agau.gastro.org This independent educational program was supported by an independent medical education grant from Pfizer

In this episode of the AGA Perspective series, Dr. Gyanprakash Ketwaroo hosts a discussion on the best practices for removing large or complex colon polyps. Joined by Drs. Jeffrey Mosko and Moamen Gabr, the conversation explores the evolution of endoscopic techniques, the importance of careful polyp selection, and the challenges faced in advanced tissue resection. The experts share insights on complications associated with EMR and ESD procedures, emphasizing the need for meticulous technique to ensure patient safety. In the second half of the episode, Dr. Ira Leeds offers a counterpoint, urging caution when managing polyps in the cecum and rectum, while highlighting the role of minimally invasive surgical approaches.

There is some debate about when to recommend cessation of surveillance colonoscopy, especially in those who are 75-85 years old. In this episode of the AGA Perspectives series, Dr. Gyanprakash Ketwaroo and Dr. Moamen Gabr are joined by Dr. Mariam Naveed and Dr. Petr Protiva to discuss this common but tricky topic.

Welcome to episode one of our six-part series on hepatic encephalopathy (HE), a major complication and a frequent cause of both initial hospitalization and readmission in cirrhotic patients. In this episode, Dr. Robert Brown, chief of the division of gastroenterology and hepatology at Weill Cornell Medicine, is joined by Dr. Robert Rahimi, a board-certified physician in transplant hepatology, gastroenterology and internal medicine practicing at Baylor University Medical Center, as well as an associate professor of medicine at Texas A&M. They will discuss current and emerging treatment modalities for HE. To claim CME for listening, please visit AGA University at agau.gastro.org This independent educational program was developed in collaboration with the Society for Hospital Medicine and supported by an independent medical education grant from Salix Pharmaceuticals, a division of Bausch Health US LLC. 

In episode two of our six-part series on hepatic encephalopathy (HE), Dr. Lisa Byers, a hospitalist and assistant professor in hospital medicine at the University of Rochester Medical Center, is joined by Dr. Elliot Tapper, an associate professor in the division of gastroenterology and hepatology at University of Michigan, the director of the Michigan cirrhosis program and the editor in chief of Hepatology Communications. They discuss the changing epidemiology of cirrhosis and hepatic encephalopathy. To claim CME for listening, please visit AGA University at agau.gastro.org This independent educational program was developed in collaboration with the Society for Hospital Medicine and supported by an independent medical education grant from Salix Pharmaceuticals, a division of Bausch Health US LLC.  

In episode three of our six-part series on hepatic encephalopathy (HE), Dr. Robert Brown, chief of the division of gastroenterology and hepatology at Weill Cornell Medicine, is joined by co-host Dr. Lisa Byers, an assistant professor within the hospital medicine department at the University of Rochester School of Medicine. They discuss the inadequate practices for HE management in the inpatient setting. To claim CME for listening, please visit AGA University at agau.gastro.org This independent educational program was developed in collaboration with the Society for Hospital Medicine and supported by an independent medical education grant from Salix Pharmaceuticals, a division of Bausch Health US LLC. 

In episode four of our six-part series on hepatic encephalopathy (HE), Dr. Robert Brown, chief of the division of gastroenterology and hepatology at Weill Cornell Medicine, is joined by Dr. Alpesh Amin, a professor of medicine at the University of California, Irvine ( UCI), the endowed chair of the UCI School of Medicine Department of Medicine, and the executive director of UCI's Hospitalist Program. They discuss missed diagnosis in the inpatient setting. To claim CME for listening, please visit AGA University at agau.gastro.org. This independent educational program was developed in collaboration with the Society for Hospital Medicine and supported by an independent medical education grant from Salix Pharmaceuticals, a division of Bausch Health US LLC. 

In episode five of our six-part series on hepatic encephalopathy (HE), Dr. Robert Brown, chief of the division of gastroenterology and hepatology at Weill Cornell Medicine, is joined by Dr. Craig Rosenstengle, a fellow at Baylor University Medical Center in the combined gastroenterology and transplant hepatology pathway. They will discuss hepatic encephalopathy and strategies to prevent readmissions from inadequate transitions of care. To claim CME for listening, please visit AGA University at agau.gastro.org This independent educational program was developed in collaboration with the Society for Hospital Medicine and supported by an independent medical education grant from Salix Pharmaceuticals, a division of Bausch Health US LLC. 

In our final episode on hepatic encephalopathy (HE), Dr. Lisa Byers, a hospitalist and assistant professor in hospital medicine at the University of Rochester Medical, is joined by co-host Dr. Robert Brown, chief of the division of gastroenterology and hepatology at Weill Cornell Medicine. They delve into the article "Specific Challenges in Geriatric Cirrhosis and Hepatic Encephalopathy," authored by Drs. Jasmohan S. Bajaj, Angela Gentilly, James Wade, and Michael Godschalk, and published in Clinical Gastroenterology and Hepatology. Together, they explore best practices for staying current with the evolving literature and research on these conditions and discuss strategies for integrating new insights into daily clinical practice. To claim CME for listening, please visit AGA University at agau.gastro.org. This independent educational program was developed in collaboration with the Society for Hospital Medicine and supported by an independent medical education grant from Salix Pharmaceuticals, a division of Bausch Health US LLC. 

Welcome to a special two-episode series: Do You See What I-SEE? A Practical How-To for Using Eosinophilic Esophagitis Severity Tools. These episodes have been developed in partnership between American Gastroenterological Association (AGA) and Projects In Knowledge (PIK) Powered By Kaplan and are featured in both AGA’s Inside Scope podcast channel as well as PIK’s Morning Commute podcast channel. Without a standardized approach to severity assessment, eosinophilic esophagitis (EoE) is challenging to evaluate and monitor. To address this, the Index of Severity in EoE (I-SEE) was developed by leading experts in collaboration with the American Gastroenterological Association (AGA) and is designed to be easily used in routine practice. In this episode, Drs. Evan Dellon and Nirmala Gonsalves discuss the roles of different assessment tools in clinical practice, how they traditionally evaluate disease severity, and why the EoE community saw a need for something like the I-SEE Clinical Index. Supported by educational grants from Bristol Myers Squibb and Takeda Pharmaceuticals U.S.A., Inc. Visit https://suiteweb.atpointofcare.com/#library/eoe/2658.01/page/0 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

Welcome to a special two-episode series: Do You See What I-SEE? A Practical How-To for Using Eosinophilic Esophagitis Severity Tools. These episodes have been developed in partnership between American Gastroenterological Association (AGA) and Projects In Knowledge (PIK) Powered By Kaplan and are featured in both AGA’s Inside Scope podcast channel as well as PIK’s Morning Commute podcast channel. Without a standardized approach to severity assessment, eosinophilic esophagitis (EoE) is challenging to evaluate and monitor. To address this, the Index of Severity in EoE (I-SEE) was developed by leading experts in collaboration with the American Gastroenterological Association (AGA) and is designed to be easily used in routine practice. In this episode, Dr. Evan Dellon and Dr. Emily McGowan discuss the features measured by the I-SEE clinical index and its role in evaluating EoE severity, as well as evidence behind the ongoing validation of this tool and implications for future use. Supported by educational grants from Bristol Myers Squibb and Takeda Pharmaceuticals U.S.A., Inc. Visit https://suiteweb.atpointofcare.com/#library/eoe/2658.02/page/0 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.